Josip Bago

The effectiveness of systemic eradication therapy against oral <i>Helicobacter pylori</i>

Ivona Bago, Josip Bago, Vanda Plečko et al. · Journal of Oral Pathology and Medicine · 2010 · 31 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +11

Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial

Josip Bago, Karolina Majstorović, Željka Belošić-Halle et al. · Annals of Clinical Microbiology and Antimicrobials · 2010 · 24 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial

Josip Bago, Branko Pevec, Monika Tomić et al. · Wiener klinische Wochenschrift · 2009 · 22 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.

Josip Bago, Željka Belošić Halle, Dean Strinić et al. · PubMed · 2002 · 22 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens forHelicobacter pylori infection

Josip Bago, Anita Galović, Željka Belošić Halle et al. · Wiener klinische Wochenschrift · 2004 · 15 citations

Pharmacy, Pharmacology, Pharmacotherapy +13